题名 | Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies | 链接 | https://jamanetwork.com/journals/jamaneurology/article-abstract/2752284 |
https://jamanetwork.com/journals ... le-abstract/2752284 |